Read-Gene S.A. (WSE:RDG)
4.880
+0.180 (3.83%)
Last updated: Nov 3, 2026, 12:25 PM CET
Read-Gene Market Cap
Read-Gene has a market cap or net worth of 57.54 million as of November 3, 2026. It is the 39,198th most valuable company in the world and the 328th biggest in Poland. Its market cap has decreased by 18.67% in one year.
Market Cap
57.54M
Enterprise Value
60.49M
Revenue
16.66M
Global Rank
Country Rank
#328 Poland
PE Ratio
112.26
ChartMarket Cap Chart
Since February 12, 2009, Read-Gene's market cap has increased from 31.83M to 57.54M, an increase of 80.74%. That is a compound annual growth rate of 3.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 57.54M | -10.62% |
| Dec 30, 2025 | 64.37M | 10.08% |
| Dec 30, 2024 | 58.48M | -14.48% |
| Dec 29, 2023 | 68.38M | 124.81% |
| Dec 30, 2022 | 30.42M | -8.19% |
| Dec 29, 2021 | 33.13M | 8.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 318.31M |
| BIOTON | 295.80M |
| Synthaverse | 198.41M |
| Mabion | 124.61M |
| Poltreg | 116.26M |
| Molecure | 111.26M |
| NanoGroup | 97.62M |
| Urteste | 64.25M |